Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis-Reference-Cited by-同舟云学术

Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis

Published:2017-02-12 Issue:10 Volume:64 Page:1328-1334
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Venkatesan Sudhir,Myles Puja R.,Leonardi-Bee Jo,Muthuri Stella G.,Al Masri Malak,Andrews Nick,Bantar Carlos,Dubnov-Raz Gal,Gérardin Patrick,Koay Evelyn S. C.,Loh Tze Ping,Memish Ziad,Miller Elizabeth,Oliva Maria E.,Rath Barbara A.,Schweiger Brunhilde,Tang Julian W.,Tran Dat,Vidmar Tjasa,Waight Pauline A.,Nguyen-Van-Tam Jonathan S.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/64/10/1328/17827785/cix127.pdf

Reference24 articles.

1. Antivirals for influenza: where now for clinical practice and pandemic preparedness?;Lancet,2014

2. Evidence and policy for influenza control;Euro Surveill,2014

3. Neuraminidase inhibitors for preventing and treating influenza in adults and children;Cochrane Database Syst Rev,2014

4. Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009–2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients;J Infect Dis,2013

5. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data;PRIDE Consortium Investigators;Lancet Respir Med,2014

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recommendations for Prevention and Control of Influenza in Children, 2024–2025: Technical Report;Pediatrics;2024-08-26

2. Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antivirals;Journal of Medical Economics;2024-02-13

3. Effectiveness of Influenza Vaccination and Early Antiviral Treatment in Reducing Pneumonia Risk in Severe Influenza Cases;Vaccines;2024-02-07

4. Recommendations for the management of children with influenza in a primary care setting – COMPAS INFLUENZA. Update for the 2023/2024 season;Pediatria i Medycyna Rodzinna;2023-12-29

5. Influenza;Flora the Journal of Infectious Diseases and Clinical Microbiology;2023-12-22